SIENNA BIOPHARMACEUTICALS IN's ticker is SNNAQ and the CUSIP is 82622H108. A total of 61 filers reported holding SIENNA BIOPHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $11,000 | -72.5% | 52,553 | +13.2% | 0.00% | – |
| Q2 2019 | $40,000 | -63.3% | 46,435 | -0.8% | 0.00% | – |
| Q1 2019 | $109,000 | +179.5% | 46,809 | +180.3% | 0.00% | – |
| Q4 2018 | $39,000 | -89.0% | 16,700 | -30.5% | 0.00% | – |
| Q3 2018 | $356,000 | +67.9% | 24,035 | +72.5% | 0.00% | – |
| Q2 2018 | $212,000 | -5.8% | 13,933 | +16.1% | 0.00% | – |
| Q1 2018 | $225,000 | +15.4% | 12,001 | +11.7% | 0.00% | – |
| Q4 2017 | $195,000 | – | 10,742 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|